Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since. 

Share:
More In Science
Be Well: Relationships Critical to Well-Being
Andrea Miller, founder and CEO of Your Tango, discusses why the world is in a global relationship crisis and a loneliness epidemic that has accelerated dramatically, especially since the pandemic. "More people are working from home and so they're not getting in-person connection," she said.
Load More